Dexilend 30 mg (Capsule (Enteric Coated))
Unit Price: ৳ 10.00 (9 x 10: ৳ 900.00)
Strip Price: ৳ 100.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Dexlansoprazole |
| Company | Ziska pharmaceuticals ltd |
| Also available as |
Indications
- Healing of Erosive Esophagitis
- Maintenance of Healed Erosive Esophagitis
- Symptomatic Non-Erosive Gastroesophageal Reflux Disease
Pharmacology
- Proton Pump Inhibitor
- Suppression of Gastric Acid Secretion
- Specific Inhibition of (H+/K+)-ATPase
- Dual Delayed Release (DDR) Formulation
- Metabolism in the Liver
- Excretion by Urine
Dosage
- 30 mg Once Daily for Maintenance of Healed Erosive Esophagitis and Relief of Heartburn
- 30 mg Once Daily for Symptomatic Non-Erosive Gastroesophageal Reflux Disease
- 60 mg Once Daily for Healing of Erosive Esophagitis
- Dosing Recommendations for Adults and Adolescents
- MUPS (Multiple Unit Pellet System) Dosing Recommendations
Administration
- Can be Taken Without Regard to Food
- Swallowed Whole
- Alternative Administration Method for Capsules
- Missed Capsule Instructions
Interaction
- Interaction with Specific Medicines (Atazanavir, Warfarin, Tacrolimus, Clopidogrel, Methotrexate)
- No Data on Interaction with Food or Other Substances
Contraindications
- Known Hypersensitivity to Any Component of the Formulation
Side Effects
- Diarrhea
- Abdominal Pain
- Nausea
- Vomiting
- Flatulence
Pregnancy & Lactation
- Pregnancy Category B
- No Adequate and Well-Controlled Studies in Pregnant Women
- No Adequate and Well-Controlled Studies in Lactating Women
Precautions & Warnings
- Gastric Malignancy
- Clostridium difficile Associated Diarrhea
- Bone Fracture
- Hypomagnesemia
- Concomitant Use with Methotrexate
Use in Special Populations
- Use in Children & Adolescents
- Safety and Effectiveness in Patients Below 12 Years Not Established
- Geriatric Use
- No Dose Adjustment Necessary for Elderly Patients
- Renal Impairment
- No Dose Adjustment Necessary for Patients with Renal Impairment
- Hepatic Impairment
- No Dose Adjustment Necessary for Patients with Mild Hepatic Impairment
Overdose Effects
- No Reports of Significant Overdose
- Tolerability of Multiple 120 mg Doses and Single 300 mg Dose
Therapeutic Class
- Proton Pump Inhibitor
Storage Conditions
- Store Below 30°C Temperature
- Store in a Dry Place
- Protected from Light
- Keep Medicines Out of Reach of Children